Skip to content

Hypertrophic Cardiomyopathy 6 C1833236

Published: July 22, 2026Updated: August 25, 2026

A familial heart condition characterized by abnormal thickening of the heart walls. Regular monitoring and medications help manage symptoms and complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Exertional chest discomfort

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Shortness of breath

(cardiovascular)

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Beta-blocker therapy

Beta-blockers reduce heart rate and contractility, decreasing left ventricular outflow obstruction and improving exercise tolerance in HCM patients.

medication
2

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Activity restriction program

Structured avoidance of competitive sports and high-intensity activities that may trigger arrhythmias or worsen obstruction.

lifestyle

Additional treatment options

Alcohol septal ablation

Catheter-based injection of alcohol into septal perforators to induce controlled infarction, reducing septal thickness and obstruction.

procedure

Echocardiographic surveillance

Regular echocardiographic monitoring to assess septal thickness, obstruction severity, and diastolic function progression.

monitoring

Calcium channel blocker therapy

Non-dihydropyridine calcium channel blockers may be used when beta-blockers are contraindicated to reduce contractility and obstruction.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hypertrophic Cardiomyopathy 6 C1833236?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Hypertrophic Cardiomyopathy 6 C1833236. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy